Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 14.8B | 16.1B | 15.5B | 15.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 64M | 91M | 51M | 80M |
| Other operating expenses | 2.2B | 2.3B | 2.1B | 2.3B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 8.1B | 9.2B | 9.1B | 8.5B |
| Tax provision | 1.8B | 2.0B | 2.0B | 1.9B |
| Net income | 6.3B | 6.8B | 7.2B | 6.8B |
| Basic EPS | 3.2 | 3.5 | 3.6 | 3.4 |
| Diluted EPS | 3.2 | 3.5 | 3.6 | 3.4 |
| Basic average shares | 21.6B | 21.6B | 21.6B | 21.6B |
| Diluted average shares | 21.6B | 21.6B | 21.6B | 21.6B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 8.1B | 8.7B | 9.3B | 8.8B |
| Minority interests | -1M | -3M | 0 | -1M |
| Preferred stock dividends | — | — | — | — |